Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes

Altayeb Ahmed, Hasnat Amin, Fotios Drenos, Naveed Sattar, Hanieh Yaghootkar

Diabetes Care 2023;46(10):1783–1791

https://doi.org/10.2337/dc23-0855

Published: 09 August 2023

View article titled, Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes

Journal Articles

The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study

Manel Mata-Cases, Beatriz Rodríguez-Sánchez, Dídac Mauricio, Jordi Real, Bogdan Vlacho, Josep Franch-Nadal, Juan Oliva

Diabetes Care 2020;43(4):751–758

https://doi.org/10.2337/dc19-0573

Published: 06 February 2020

View article titled, The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study

Includes: Supplementary data

Journal Articles

The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes

Karin Littmann, Tigist Wodaje, Michael Alvarsson, Matteo Bottai, Mats Eriksson, Paolo Parini, Jonas Brinck

Diabetes Care 2020;43(8):1851–1858

https://doi.org/10.2337/dc19-1398

Published: 20 December 2019

View article titled, The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes

Journal Articles

High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes

Tomas Vaisar, Jenny E. Kanter, Jake Wimberger, Angela D. Irwin, John Gauthier, Emily Wolfson, Vanessa Bahnam, I-Hsien Wu, Hetal Shah, Hillary A. Keenan, Carla J. Greenbaum, George L. King, Jay W. Heinecke, Karin E. Bornfeldt

Diabetes Care 2020;43(1):178–186

https://doi.org/10.2337/dc19-0772

Published: 09 October 2019

View article titled, High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes

Includes: Supplementary data

Journal Articles

Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications

Gail Musen, Liane J. Tinsley, Katrina A. Marcinkowski, David Pober, Jennifer K. Sun, Maya Khatri, Richie Huynh, Annie Lu, George L. King, Hillary A. Keenan

Diabetes Care 2018;41(8):1749–1756

https://doi.org/10.2337/dc17-1955

Published: 05 June 2018

View article titled, Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications

Includes: Supplementary data

Journal Articles

Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications

Rena M. Pollack, Marc Y. Donath, Derek LeRoith, Gil Leibowitz

Diabetes Care 2016;39(Supplement_2):S244–S252

https://doi.org/10.2337/dcS15-3015

Published: 16 July 2016

View article titled, Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications

Journal Articles

Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37: 1353–1359

Juuso I. Blomster, Sophia Zoungas, John Chalmers, Qiang Li, Clara K. Chow, Mark Woodward, Giuseppe Mancia, Neil Poulter, Bryan Williams, Stephen Harrap, Bruce Neal, Anushka Patel, Graham S. Hillis

Diabetes Care 2015;38(7):1393

https://doi.org/10.2337/dc15-er07a

Published: 11 June 2015

View article titled, Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37: 1353–1359

Journal Articles

Association of Glycation Gap With Mortality and Vascular Complications in Diabetes

Ananth U. Nayak, MRCP, Alan M. Nevill, PHD, Paul Bassett, MSC, Baldev M. Singh, MD

Diabetes Care 2013;36(10):3247–3253

https://doi.org/10.2337/dc12-1040

Published: 14 September 2013

View article titled, Association of Glycation Gap With Mortality and Vascular Complications in Diabetes

Includes: Supplementary data

Journal Articles

NH₂-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α

Gabriella Gruden, PHD, Federica Barutta, PHD, Nish Chaturvedi, MRCP, Casper Schalkwijk, PHD, Coen D. Stehouwer, PHD, Silvia Pinach, MSC, Maria Manzo, BSC, Maria Loiacono, BSC, Marinella Tricarico, MD, Giulio Mengozzi, MD, Daniel R. Witte, PHD, John H. Fuller, FRCP, Paolo Cavallo Perin, MD, Graziella Bruno, MD

Diabetes Care 2012;35(9):1931–1936

https://doi.org/10.2337/dc12-0089

Published: 14 August 2012

View article titled, NH<sub>2</sub>-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: <subtitle>The role of tumor necrosis factor-α</subtitle>

Includes: Supplementary data

Journal Articles

Can Protein Kinase C β–Selective Inhibitor, Ruboxistaurin, Stop Vascular Complications in Diabetic Patients?

Zhiheng He, MD, PHD, George L. King, MD

Diabetes Care 2005;28(11):2803–2805

https://doi.org/10.2337/diacare.28.11.2803

Published: 01 November 2005

View article titled, Can Protein Kinase C β–Selective Inhibitor, Ruboxistaurin, Stop Vascular Complications in Diabetic Patients?

Journal Articles

A Common Glu²⁹⁸→Asp (894G→T) Mutation at Exon 7 of the Endothelial Nitric Oxide Synthase Gene and Vascular Complications in Type 2 Diabetes

Hua Cai, MBBS, Xingli Wang, MBBS, PHD, Stephen Colagiuri, MD, FRACP, David E L Wilcken, MD, FRCP, FRACP

Diabetes Care 1998;21(12):2195–2196

https://doi.org/10.2337/diacare.21.12.2195

Published: 01 December 1998

View article titled, A Common Glu<sup>298</sup>→Asp (894G→T) Mutation at Exon 7 of the Endothelial Nitric Oxide Synthase Gene and Vascular Complications in Type 2 Diabetes

Journal Articles

Hemostasis Variables in Type I Diabetic Patients Without Demonstrable Vascular Complications

Charbel El Khawand, MD, Jacques Jamart, MD, Julian Donckier, MD, Bernard Chatelain, PHD, Edith Lavenne, MD, Maurice Moriau, MD, Martin Buysschaert, MD

Diabetes Care 1993;16(8):1137–1145

https://doi.org/10.2337/diacare.16.8.1137

Published: 01 August 1993

View article titled, Hemostasis Variables in Type I Diabetic Patients Without Demonstrable Vascular Complications

Journal Articles

Determinants of Diabetes Mellitus in the Pima Indians

William C Knowler, MD, DRPH, Mohammed F Saad, MD, MRCP, David J Pettitt, MD, Robert G Nelson, MD, MPH, Peter H Bennett, MB, FRCP, FFCM

Diabetes Care 1993;16(1):216–227

https://doi.org/10.2337/diacare.16.1.216

Published: 01 January 1993

View article titled, Determinants of Diabetes Mellitus in the Pima Indians

Journal Articles

Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes

Om P Ganda, MD, Charles F Arkin, MD

Diabetes Care 1992;15(10):1245–1250

https://doi.org/10.2337/diacare.15.10.1245

Published: 01 October 1992

View article titled, Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes

Journal Articles

Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective

Richard P Donahue, PHD, Trevor J Orchard, MBBCH, MMEDSCI

Diabetes Care 1992;15(9):1141–1155

https://doi.org/10.2337/diacare.15.9.1141

Published: 01 September 1992

View article titled, Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective

Journal Articles

Advances and Pathophysiology of Vascular Complications of Diabetes

John T Gwynne, MD, Donald E McMillan, MD

Diabetes Care 1991;14(2):148

https://doi.org/10.2337/diacare.14.2.148

Published: 01 February 1991

View article titled, Advances and Pathophysiology of Vascular Complications of Diabetes

Journal Articles

Tissue Plasminogen Activator Inhibition in Diabetes Mellitus

Michael Small, MD, Cornelius Kluft, PhD, Angus C MacCuish, MD, Gordon D O Lowe, MD

Diabetes Care 1989;12(9):655–658

https://doi.org/10.2337/diacare.12.9.655

Published: 01 October 1989

View article titled, Tissue Plasminogen Activator Inhibition in Diabetes Mellitus

Journal Articles

Referral Bias in Diabetes Research

L Joseph Melton, III, James W Ochi, B.A., Pasquale J Palumbo, M.D., Chu Pin Chu, M.S.

Diabetes Care 1984;7(1):12–18

https://doi.org/10.2337/diacare.7.1.12

Published: 01 January 1984

View article titled, Referral Bias in Diabetes Research

Journal Articles

Prevalence of Major Vascular Complications at the Initial Visit Among Japanese Diabetic Patients

Eishi Miki, Yasuo Akanuma, Yasunori Kanazawa, Hiroyuki Sando, Masatoshi Kikuchi, Shoji Kawazu, Kinori Kosaka

Diabetes Care 1979;2(2):171–174

https://doi.org/10.2337/diacare.2.2.171

Published: 01 March 1979

View article titled, Prevalence of Major Vascular Complications at the Initial Visit Among Japanese Diabetic Patients

Journal Articles

Diabetes Mellitus and Its Vascular Complications in Japanese Migrants on the Island of Hawaii

Ryoso Kawate, Michio Yamakido, Yukio Nishimoto, Peter H Bennett, Richard F Hamman, William C Knowler

Diabetes Care 1979;2(2):161–170

https://doi.org/10.2337/diacare.2.2.161

Published: 01 March 1979

View article titled, Diabetes Mellitus and Its Vascular Complications in Japanese Migrants on the Island of Hawaii

NARROW

Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes

The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study

The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes

High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes

Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications

Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications

Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37: 1353–1359

Association of Glycation Gap With Mortality and Vascular Complications in Diabetes

NH₂-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α

Can Protein Kinase C β–Selective Inhibitor, Ruboxistaurin, Stop Vascular Complications in Diabetic Patients?

A Common Glu²⁹⁸→Asp (894G→T) Mutation at Exon 7 of the Endothelial Nitric Oxide Synthase Gene and Vascular Complications in Type 2 Diabetes

Hemostasis Variables in Type I Diabetic Patients Without Demonstrable Vascular Complications

Determinants of Diabetes Mellitus in the Pima Indians

Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes

Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective

Advances and Pathophysiology of Vascular Complications of Diabetes

Tissue Plasminogen Activator Inhibition in Diabetes Mellitus

Referral Bias in Diabetes Research

Prevalence of Major Vascular Complications at the Initial Visit Among Japanese Diabetic Patients

Diabetes Mellitus and Its Vascular Complications in Japanese Migrants on the Island of Hawaii

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only